Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NutriKane D is a plant-based functional food and dietary supplement developed by the Australian company MediKane. It is composed of a proprietary blend of sugarcane fiber (K-Fibre), red sorghum, natural fruit extracts, and bio-available chromium. Unlike conventional pharmaceuticals, NutriKane D works by nourishing the gut microbiome and stimulating the body's natural production of incretin hormones, specifically glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2). These hormones help improve insulin sensitivity, lower the glycemic index of consumed foods, and promote the production of short-chain fatty acids (SCFAs). The product is primarily indicated for the management of blood glucose levels in individuals with type 2 diabetes and pre-diabetes, as well as for supporting gut health and weight management.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on NutriKane D.